S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PIRS Pieris Pharmaceuticals Inc

13.60

-2.53 (-15.69%)

14 Dec 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals Inc News

Form 425 - Prospectuses and communications, business combinations
Friday 13 December 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 13 December 2024 (2 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 7 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Wednesday 4 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations
Friday 8 November 2024 (1 month ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 17 October 2024 (2 months ago) • Edgar (US Regulatory)

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Thursday 17 October 2024 (2 months ago) • GlobeNewswire Inc.

More Pieris Pharmaceuticals Inc News Articles

Woodside Petroleum

National Australia Bank

Invesco QQQ Trust Series 1

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions